Updated Jul 16, 2026
Seith Douglas J has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Douglas J. Seith is the Chief Operating Officer at AtriCure, Inc., a company specializing in surgical treatments for atrial fibrillation and related therapies. He has been involved in the medical device industry, contributing to the company's operational strategies.
| Role | Chief Operating Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | ATRC | AtriCure, Inc. | A — Grant or award | 527 | $23.78 | $13K |
| 2026-03-03 | ATRC | AtriCure, Inc. | F — Tax withholding / forfeiture | 22.9K | $31.26 | $717K |
| 2026-03-03 | ATRC | AtriCure, Inc. | A — Grant or award | 25.5K | $0.00 | |
| 2026-03-03 | ATRC | AtriCure, Inc. | A — Grant or award | 42.4K | $0.00 | |
| 2025-06-30 | ATRC | AtriCure, Inc. | A — Grant or award | 550 | $25.84 | $14K |
Douglas J. Seith is the Chief Operating Officer at AtriCure, Inc., a company specializing in surgical treatments for atrial fibrillation and related therapies. He has been involved in the medical device industry, contributing to the company's operational strategies.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Seith Douglas J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.